Tenon Medical Inc. logo

Tenon Medical Inc.

TNON | NASDAQ
Chart Builder DCF Calculator
$3.73
-$0.35 (-8.58%)
At close: Sep 21, 2026, 4:00 PM ET
$3.67
-$0.06 (-1.71%)
Pre-market: Sep 22, 2026, 5:45 AM ET

Market Data

Market Cap
$2.03M
Enterprise Value
$5.85M
Beta
1.36
Average Volume
960.64K
Shares Outstanding (Diluted)
325K
Shares Change YoY
51.23%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US88066N4025

Price Performance

Price Change 1M
-39.8%
Price Change 3M
-77.0%
Price Change 6M
-86.3%
Price Change YTD
-89.1%
Price Change 1Y
-91.3%
Price Change 3Y
-99.2%
Price Change 5Y
-100.0%
1M CAGR (ann.)
-30.6%
1Y CAGR (ann.)
-90.0%
5Y CAGR (ann.)
N/A
All-Time CAGR
-88.8%

Valuation

PE Ratio
-0.08
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
0.35
Forward PS
0.30
PB Ratio
-1.06
P/FCF Ratio
-0.15
P/Adj. FCF Ratio
-0.14
P/OCF Ratio
-0.10
EV/Sales
1.10
EV/EBIT
-0.62
EV/EBITDA
-0.47
EV/FCF
-0.48
Earnings Yield
-1240.2%
FCF Yield
-652.1%
Adj. FCF Yield
-713.9%

Financial Health

Net Debt
$4M
Total Debt
$5.68M
Cash & Short-Term Investments
$1.68M
Total Assets
$9.92M
Current Ratio
0.58
Quick Ratio
0.48
Debt / Equity Ratio
-3.26
Debt / EBITDA
-0.46
Debt / FCF
-0.47
OCF / Debt
-2.07
Interest Coverage
-19.12
Altman Z-Score
-15.45
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
66.3%
Operating Profit Margin
-242.5%
EBITDA Margin
-234.2%
Net Profit Margin
-256.3%
FCF Margin
-226.5%
Adj. FCF Margin
-248.0%
SBC / Revenue
21.5%
SBC Impact (per share)
-9.5%

Returns

Return on Assets
-137.7%
Return on Equity
-547.1%
Return on Invested Capital
-209.7%
Return on Capital Employed
-799.4%
Return on Tangible Assets
-193.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
47.5%
Revenue CAGR 5Y
150.9%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
118.6%
EPS CAGR 5Y
85.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-7.4%
FCF CAGR 5Y
-2.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
2
EPS Growth Next 3Y
30.8%
Revenue Growth Next 3Y
75.3%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$5.62
EPS Growth Est (next Q)
-59.8%
Revenue Est (next Q)
$1.43M
Revenue Growth Est (next Q)
22.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2.25
Price Target Upside
-39.7%

Cash Flow

Operating Cash Flow
$-11.77M
Free Cash Flow
$-12.08M
Adj. Free Cash Flow
$-13.22M
FCF Per Share
-$36.81
OCF Per Share
-$35.87
OCF/S Ratio
-220.7%

Income Statement

Revenue
$5.33M
Gross Profit
$3.53M
Operating Income
$-12.93M
EBITDA
$-12.33M
Net Income
$-6.14M
EPS (Diluted)
-$46.26
Revenue / Employee
$205.04K
Profit / Employee
$-236.12K
Employees
26

© 2026 bestshares.com. All rights reserved.